No. 23A427
Hi-Tech Pharmaceuticals, Inc., et al. v. Federal Trade Commission
Tags: administrative-enforcement antitrust appellate-review ftc-act medical-practice statutory-authority
Latest Conference:
N/A
Question Presented (AI Summary)
Whether the Federal Trade Commission's administrative enforcement action against a medical practice for alleged anticompetitive conduct exceeds its statutory authority under the FTC Act
Question Presented (OCR Extract)
No question identified. : 2. This Court has jurisdiction under 28 U.S.C. § 1254(1) from the entry of a final judgment by the United States Court of Appeals for the Eleventh Circuit. 3. The final judgment sought to be reviewed was entered in the United States Court of Appeals for the Eleventh Circuit on August 29, 2023. FTC v. Nat Urological Grp., Inc., 80 F.4th 1236 (11th Cir. 2023). Genuine copies of the opinion and judgment are filed with this application in an
Docket Entries
2023-11-13
Application (23A427) granted by Justice Thomas extending the time to file until December 27, 2023.
2023-11-08
Application (23A427) to extend the time to file a petition for a writ of certiorari from November 27, 2023 to January 26, 2024, submitted to Justice Thomas.
Attorneys
Federal Trade Commission, et al.
Elizabeth B. Prelogar — Solicitor General, Respondent
Elizabeth B. Prelogar — Solicitor General, Respondent
Hi-Tech Pharmaceuticals, Inc., et al.
Robert Foust Parsley — Miller & Martin, PLLC, Petitioner
Robert Foust Parsley — Miller & Martin, PLLC, Petitioner